
FitRx Review
Semaglutide GLP-1 weight-loss telehealth · Independently scored 7.8/10
Best for: insured patients seeking brand-name GLP-1 access with compounded fallback
FitRx scores highest on state availability and ease of access.
Semaglutide
What the monthly price covers
Medication
Included
Provider visits
Included
Shipping
Included
Lab work
Not disclosed
Coaching
Not disclosed
No insurance needed · Vetted by our editors
FitRx offers brand-name GLP-1s (Ozempic, Wegovy, Zepbound, Mounjaro) with insurance coordination as low as $25/month, plus compounded semaglutide from $151/month without insurance. LegitScript certified. Available in all 50 states + DC.
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
Vetted alternatives to FitRx
RNK Health
Best for: compounded GLP-1 alongside NAD+, peptide and longevity add-ons
Editorial score · methodology
Wellorithm
Best for: compounded GLP-1 access with oral tablet options across 49 states
Editorial score · methodology
Editorial score · methodology
FitRx at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Wegovy, Ozempic, Zepbound, Mounjaro
- Starting price
- $25/mo (With insurance coordination)
- What's included
- Medication · Consult · Shipping
- Availability
- All 50 states
- FDA status
- 1 FDA warning letter on record — see below
How we scored FitRx
Each dimension is scored algorithmically from FitRx’s real pricing, drugs offered, verification status, and disclosed inclusions — using the same six-dimension framework we apply to every provider.
Value25%
8.3/10At $151/mo, FitRx runs about 11% below the $169 median for GLP-1 providers.
Effectiveness25%
8.6/10FitRx offers both semaglutide and tirzepatide — the two GLP-1 molecules with the strongest published weight-loss trial outcomes. FDA-approved brand options are available alongside compounded versions.
User Experience15%
7.6/10Online intake and platform experience — consult included in the price; 8 platform features disclosed.
Trust & Safety15%
6.3/10Key details fully confirmed by our editors; an FDA warning letter is on file (see flag above) (last checked 2026-08-02).
Accessibility10%
8.8/10FitRx treats patients in all 50 states. Insurance pathways are offered for eligible patients.
Support10%
6.1/10FitRx provides standard clinician follow-up; no extended coaching or community program is disclosed.
Providers that don’t post pricing up front score lower on Value and carry a cost-transparency note in their review. Read the full methodology →
How we verified this FitRx review
Last checked August 2026- Confirmed current pricing across 2 dose/plan tiers
- Confirmed availability in all 50 states
- Confirmed what the monthly price does and doesn't include
- Checked the FDA warning-letter database for enforcement actions
- Walked the public intake/checkout flow on the provider's site
Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records — see the sources below. Editorial confidence in this data: high.
What to expect when you sign up with FitRx
We walked FitRx’s public signup flow in July 2026 to document the process — the steps, pricing transparency, and what’s required — before you commit. (We don’t create accounts, enter medical information, or check out; this is the observable funnel, not a prescribing outcome.)
- 1Answer eligibility questions to see if you qualify (routes to care.fitrxapp.com/get-started).
- 2A provider licensed in your state reviews your responses.
- 3If approved, medication is filled by U.S.-based pharmacies.
- 4Medication ships free to your door with coordinator and optional coaching support.
- GLP-1 offerings are explicit: brand-name Ozempic, Wegovy, Zepbound, Mounjaro plus semaglutide and other compounded GLP-1s.
- Pricing shown includes brand-name as low as $25/mo with insurance and semaglutide at $151/mo when purchased quarterly; coordinators work to lower cost via insurance optimization.
- Free consultations with licensed providers are advertised, with 24/7 provider access.
- Lab testing is presented as an option ('Start my labs') rather than a stated requirement.
- Free shipping from U.S. pharmacies is advertised; no support phone/email was listed on the pages fetched.
GLP-1 medications FitRx offers
Tap any medication to read our plain-English guide — how it works, dosing, side effects, and what the trials found.
Pricing
Prices re-verified
With insurance coordination
Ready to get started?
Plans and promotions change often — check FitRx's current pricing and active discounts before you decide.
What we like
- Insurance coordination for brand-name GLP-1s — as low as $25/mo
- All four major brand-name GLP-1s available (Ozempic, Wegovy, Zepbound, Mounjaro)
- LegitScript certified
- All 50 states + DC coverage
- Compounded semaglutide from $151/mo quarterly for uninsured patients
- Free consultations
Watch-outs
- Insurance coordination may not work for all plans
- Broader platform (birth control, mental health, hair loss, ED, skincare, primary care)
- Compounded option is semaglutide only — no compounded tirzepatide
FitRx: the rare platform that tries insurance first
Most GLP-1 telehealth startups quietly skip insurance entirely and sell you cash-pay compounded medication. FitRx is built around the opposite bet. Its headline pitch is that it will coordinate with your insurer to get you a real brand-name GLP-1 — Ozempic, Wegovy, Zepbound, or Mounjaro — and if your plan plays along, your share can land as low as roughly twenty-five dollars a month. For an insured patient who actually wants the FDA-approved pen and not a compounded copy, that is a genuinely different proposition, and it's the main reason to look here.
The catch is in the word 'coordination.' FitRx isn't your insurer, and it can't force a plan to cover a weight-loss drug it has decided to exclude. So the low number is a best case, not a promise. If your coverage cooperates, FitRx is one of the cheapest legitimate routes to brand-name medication in this whole category. If it doesn't, you fall back to the cash compounded plan — and that's where most people will actually land.
How the two-track pricing really works
There are two distinct paths, and they are priced nothing alike. The brand track runs through your insurance and is the one that can reach the low double digits per month — but only because your plan is paying the rest of a list price that runs well over a thousand dollars. The cash track is the fallback: compounded semaglutide starting at $151 a month, and that rate is quoted on a quarterly purchase, meaning you commit to and pay for a three-month supply up front rather than month to month.
For context, $151 sits a little under the category median of about $169, so the cash compounded plan is competitively priced but not a category-low loss leader. FitRx is currently running a limited-time discount on its weight-loss program as well, though promotional pricing comes and goes — treat any teaser rate as a reason to confirm the real ongoing number before you commit to a quarter.
- Brand track: Ozempic, Wegovy, Zepbound, Mounjaro through insurance coordination — potentially a very low monthly copay, entirely dependent on your plan.
- Cash track: compounded semaglutide from $151/month, billed quarterly, no insurance required.
- What the cash price includes: the medication itself, free shipping from U.S.-based pharmacies, and 24/7 access to licensed providers at no extra cost.
Medications and how they reach you
On the brand side FitRx covers all four of the major GLP-1 and dual-agonist pens, which means both semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) are on the menu if your insurance approves them. On the cash side, though, the only compounded option is semaglutide. There is no compounded tirzepatide here. If you've decided tirzepatide is the molecule you want and you don't have insurance coverage for it, FitRx simply can't serve you — that's a hard limit worth knowing before you sign up.
Everything ships from U.S.-based pharmacies with free delivery, the consultation is free, and FitRx says supplies come included with the medication. Care is delivered by licensed providers available in all fifty states plus Washington, D.C., so geography isn't a barrier the way it is with some smaller operators.
What actually sets FitRx apart
Two things. First is the insurance-first model — most competitors won't even attempt it, so FitRx is one of the few places an insured patient can plausibly get a brand-name pen for a small copay rather than a four-figure cash price. Second is breadth: FitRx isn't a weight-loss specialist. It's a general telehealth platform that also handles birth control, mental health, hair loss, ED, skincare, and primary care.
That breadth cuts both ways. If you'd rather keep your prescriptions under one roof, it's a convenience. But it also means weight management is one of many lines of business rather than the entire focus, and you won't get the deep, single-minded program design you'd find at a dedicated GLP-1 clinic. There's no dedicated lab panel mentioned, and the coaching is structured as an optional add-on you choose into — it isn't baked into the base cash price the way some rivals bundle it.
Who it's for, and who should look elsewhere
- Choose FitRx if: you have insurance and want a real shot at a brand-name GLP-1 for a low copay, or you want compounded semaglutide as a clean fallback, or you like consolidating multiple health needs on one platform.
- Skip it if: you want compounded tirzepatide (not offered), you want a weight-loss-only program with built-in coaching and labs, or you have no insurance and the insurance-coordination angle — FitRx's whole selling point — doesn't apply to you.
Trust and medical oversight
FitRx is LegitScript certified, a third-party verification that the pharmacy and telehealth operation meet legal and safety standards — a badge that screens out the sketchier end of this market, and one we confirmed directly. There are no FDA warning letters or enforcement actions on file against FitRx in our records, and the platform consistently states that prescriptions come from licensed U.S. providers and that fulfillment runs through U.S.-based pharmacies. That's a reassuring baseline. As always with compounded medication, remember it isn't FDA-approved the way the brand pens are; that's a trade-off inherent to every cash compounded plan, not a FitRx-specific flaw. You can see how we weigh these factors in our scoring methodology.
Bottom line
FitRx is most compelling for insured patients — it's one of the few telehealth services that genuinely tries to get you a brand-name GLP-1 through your plan, and when that works the price is hard to beat. For everyone else, it's a solid, LegitScript-certified, nationwide compounded-semaglutide option at $151 a month, with the convenience of a broad platform behind it. Just go in clear-eyed: the eye-catching low number depends entirely on your insurance, the cash plan asks you to pay a quarter at a time, and tirzepatide isn't available unless your coverage pays for the brand.
For a side-by-side, SkinnyRx ($149.25/month) and Sunlight ($88/month) are the most comparable options to weigh against FitRx.
The Bottom Line
FitRx scores highest on state availability and ease of access.
Ready to start with FitRx?
Starting at $151/month. See current pricing and start your free consultation.
FitRx might not be your best fit if…
We rank editorially, so here’s where a different provider we track may serve you better.
- If the lowest possible monthly price is your top priority, consider Sunlight (from $88/mo).
- If you want built-in coaching and behavior-change support, consider RNK Health.
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Regulatory notice
FitRx received an FDA warning letter dated February 20, 2026
The letter concerns false & misleading claims/misbranded. FDA warning letters are public regulatory communications and do not, on their own, constitute a finding of illegal activity — companies often respond with corrective action.
Sources
The primary regulatory filings and peer-reviewed studies cited throughout this FitRx review:
Sources & methodology — as of August 2026
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
See FitRx's current pricing
Plans start at $151/month. Start your free consultation to check eligibility and today's price.